A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis
Clinical trial NCT03331835 · COMPLETED
Trial details
- NCT number
- NCT03331835
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-03
- Primary completion
- 2019-01-24
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.